Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: South Korea Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20054
20062
20072
20082
20091
20102
20112
20122
20133
20142
20151
20171
20181
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Bristol-Myers Squibb6
Pfizer4
Dong-Wook Kim2
Il-Yang Pharm. Co., Ltd.2
Accenture1
Ariad Pharmaceuticals1
Asan Medical Center1
Chong Kun Dang Pharmaceutical1
Dong-A ST Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive30
Leukemia8
Hematologic Diseases6
Leukemia, Myeloid6
Bone Marrow Diseases5
Philadelphia Chromosome5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Gastrointestinal Stromal Tumors3
Bronchiolitis Obliterans Syndrome2
Hematologic Neoplasms2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.